Company Overview of Lev Pharmaceuticals, Inc.
As of October 21, 2008, Lev Pharmaceuticals, Inc. was acquired by ViroPharma Inc. Lev Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on developing and commercializing therapeutic products for the treatment of inflammatory diseases. Its products include C1-INH that is used for the treatment of hereditary angioedema. The company was founded in 2003 and is based in New York, New York.
122 West 42nd Street
New York, NY 10168
Founded in 2003
Key Executives for Lev Pharmaceuticals, Inc.
Lev Pharmaceuticals, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|Herbal Regenesis, Inc.||United States|
|ZSX Medical, LLC||United States|
|Microfluidic Innovations LLC||United States|
|Prostagen, Inc.||United States|
|Parion Sciences, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Bridgewater, NJ | InformaticaPosted: Dec 11
- Parsippany, NJ | RGPPosted: Dec 13
- Princeton, NJ | RGPPosted: Nov 27
- Princeton, NJ | RGPPosted: Oct 21
Sponsored Financial Commentaries
To contact Lev Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.